These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Actol in the treatment of rheumatic diseases]. Furmaniuk M; Zimmermann-Górska I Reumatologia; 1974; 12(1):91-4. PubMed ID: 4546222 [No Abstract] [Full Text] [Related]
4. [Use of a new antirheumatic drug: midalgyl]. Vignon G; Laurent J; Kopp N Presse Med (1893); 1970 Nov; 78(48):2145-6. PubMed ID: 5312370 [No Abstract] [Full Text] [Related]
5. [Controlled clinical experimentation of a new synthetic preparation (MY 41-6) with anti-inflammatory, antalgic and myorelaxant effect]. Capretti G; Marinoni C Clin Ter; 1974 Feb; 68(3):233-45. PubMed ID: 4596251 [No Abstract] [Full Text] [Related]
6. [Percluson (Clophezon)--clinical drug evaluation]. Wysocka K; Szwed L Pol Tyg Lek; 1973 Nov; 28(48):1902-3. PubMed ID: 4543746 [No Abstract] [Full Text] [Related]
7. [Therapy with non-steroidal antirheumatics]. Miehle W Fortschr Med; 1981 Aug; 99(30):1189-94. PubMed ID: 6974124 [TBL] [Abstract][Full Text] [Related]
8. [Adverse effects of antirheumatics in children and adolescents]. Hoza J; Rubín A; Fink Z; Havelka S Cesk Pediatr; 1984 Sep; 39(9):536-9. PubMed ID: 6334566 [No Abstract] [Full Text] [Related]
9. [On experience with the antirheumatic agent Arcobutina]. Eberl R Munch Med Wochenschr; 1968 Dec; 110(49):2874-7. PubMed ID: 4885420 [No Abstract] [Full Text] [Related]
10. [Anti-rheumatic drugs or the drug therapy of rheumatic diseases]. Gross D Ther Umsch; 1972 Aug; 29(8):461. PubMed ID: 4538296 [No Abstract] [Full Text] [Related]
11. [New therapeutic procedures in rheumatology and their clinical verification (author's transl)]. Pavelka K; Vojtísek O Cas Lek Cesk; 1973 Dec; 112(50):1548-50. PubMed ID: 4588659 [No Abstract] [Full Text] [Related]
12. [Effect of perclusone in rheumatic diseases]. Amatuni H Reumatologia; 1973 Jan; 11(1):37-42. PubMed ID: 4540529 [No Abstract] [Full Text] [Related]
13. Drug therapy in rheumatic disease. Hill J Nursing (Lond); 1984 Nov; 2(31):905-8. PubMed ID: 6334826 [No Abstract] [Full Text] [Related]
14. [Clinical results of a new antiphlogistically effective substance, Azapropazon]. Kiesewetter E Wien Med Wochenschr; 1968 Nov; 118(44):941-3. PubMed ID: 4974675 [No Abstract] [Full Text] [Related]
15. [Clinical experiences with azapropazone in surgery]. Vokner J Schweiz Rundsch Med Prax; 1970 Dec; 59(50):1756-8. PubMed ID: 5312851 [No Abstract] [Full Text] [Related]
16. Anti-inflammatory drugs in the treatment of rheumatic diseases. Hart FD Practitioner; 1970 Nov; 205(229):597-603. PubMed ID: 5312818 [No Abstract] [Full Text] [Related]
17. [Use of Eumotol in ambulatory practice]. Simunović B Reumatizam; 1974; 21(2):57-63. PubMed ID: 4545189 [No Abstract] [Full Text] [Related]
18. [Clinical study of a new drug combination in rheumatology]. Buoniconti A; Ruiz SI; D'Auria H; Cobra CJ Hospital (Rio J); 1965 Apr; 67(4):783-8. PubMed ID: 5294228 [No Abstract] [Full Text] [Related]
19. [Pharmacological properties and therapeutic effect of azapropazon in rheumatic diseases]. Fiegel G Z Allgemeinmed; 1973 Apr; 49(12):592-4. PubMed ID: 4576254 [No Abstract] [Full Text] [Related]
20. [Use of antirheumatic agents and analgesics in old age in chronic rheumatic disorders]. Apostoloff E Z Arztl Fortbild (Jena); 1982 Apr; 76(8):328-30. PubMed ID: 6981261 [No Abstract] [Full Text] [Related] [Next] [New Search]